Back to search
FDAFDA · Food and drugs·Recall number D-0991-2019

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.

Published March 20, 2019 · Recall initiated: March 7, 2019

Summary

FDA records drug Class III recall D-0991-2019, published March 20, 2019 and initiated March 7, 2019. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 112 folding cartons; Lot: Lot # AA3280A, Exp SEP 2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
Lot
Lot # AA3280A, Exp SEP 2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61. recalled?

Yes. FDA published recall D-0991-2019 on March 20, 2019. Reported hazard: Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter